Investment analysts at UBS Group assumed coverage on shares of Surgery Partners (NASDAQ:SGRY – Get Free Report) in a report issued on Monday, Briefing.com reports. The firm set a “buy” rating and a $38.00 price target on the stock. UBS Group’s target price would suggest a potential upside of 24.75% from the stock’s current price.
SGRY has been the topic of a number of other reports. Royal Bank of Canada reiterated an “outperform” rating and set a $49.00 price objective on shares of Surgery Partners in a research note on Wednesday, August 7th. Macquarie assumed coverage on shares of Surgery Partners in a research report on Friday, June 28th. They set an “outperform” rating and a $31.00 price objective for the company. Benchmark reiterated a “buy” rating and issued a $50.00 price objective on shares of Surgery Partners in a research report on Monday, August 26th. Citigroup cut their price target on Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $43.00 price objective on shares of Surgery Partners in a report on Friday, October 4th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $39.63.
Get Our Latest Stock Report on SGRY
Surgery Partners Stock Up 0.4 %
Surgery Partners (NASDAQ:SGRY – Get Free Report) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. The firm had revenue of $762.10 million for the quarter, compared to analyst estimates of $735.94 million. Surgery Partners had a negative net margin of 1.17% and a positive return on equity of 2.96%. The firm’s revenue was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.25 EPS. Research analysts anticipate that Surgery Partners will post 0.86 EPS for the current fiscal year.
Institutional Investors Weigh In On Surgery Partners
Several hedge funds have recently made changes to their positions in the company. Creative Planning acquired a new position in Surgery Partners in the 3rd quarter worth about $258,000. Handelsbanken Fonder AB raised its holdings in Surgery Partners by 35.1% during the third quarter. Handelsbanken Fonder AB now owns 18,100 shares of the company’s stock valued at $584,000 after buying an additional 4,700 shares in the last quarter. Clearbridge Investments LLC boosted its stake in shares of Surgery Partners by 1.3% during the 2nd quarter. Clearbridge Investments LLC now owns 5,585,530 shares of the company’s stock worth $132,880,000 after acquiring an additional 73,007 shares in the last quarter. Quarry LP increased its holdings in shares of Surgery Partners by 133.1% during the 2nd quarter. Quarry LP now owns 3,082 shares of the company’s stock valued at $73,000 after acquiring an additional 1,760 shares during the last quarter. Finally, MidWestOne Financial Group Inc. raised its stake in shares of Surgery Partners by 17.1% in the 2nd quarter. MidWestOne Financial Group Inc. now owns 70,786 shares of the company’s stock valued at $1,684,000 after acquiring an additional 10,340 shares in the last quarter.
About Surgery Partners
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Recommended Stories
- Five stocks we like better than Surgery Partners
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- 3 Stocks Under $20 for Buy-and-Hold Investors Seeking Growth
- ESG Stocks, What Investors Should Know
- BlackRock’s Earnings Reveal Market Shift: Why Bonds Are in Favor
- What Are the U.K. Market Holidays? How to Invest and Trade
- JPMorgan Can Hit New Highs This Year: Here’s Why
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.